Dr. Nimesh Nagarsheth, MD

Bio

Dr. Nagarsheth graduated with honors (Alpha Omega Alpha) from Icahn School of Medicine at Mount Sinai. He completed his residency training in Obstetrics and Gynecology at Duke University Medical Center, and completed his fellowship in Gynecologic Oncology at Mount Sinai.  During his fellowship, he won numerous teaching, research, and clinical awards (including being recognized for his outstanding surgical skills by receiving first place in an international surgical film competition conducted by the prestigious American College of Obstetrics and Gynecology). During his training, Dr. Nagarsheth also conducted cutting-edge research at New York University Medical Center and Memorial Sloan-Kettering Cancer Center in New York. In his practice, Dr. Nagarsheth provides the full range of surgical and medical gynecologic oncology care.

His specialized interests include novel approaches to cancer management, cancer prevention, and advanced radical laparoscopic (minimally invasive) surgery including robotic surgery.  Dr. Nagarsheth has performed extensive research on the mechanisms of cancer prevention, including the hormonal manipulation of apoptosis. He is a lead author on a landmark study that provides the most convincing evidence yet for a novel theory of how birth control pills help prevent ovarian cancer. He has continued his research at Mount Sinai evaluating the role of hormonal effects on gynecologic organs, and has developed an extensive research background in blood management in the field of Gynecologic Oncology. Currently, Dr. Nagarsheth is considered one of the world's experts in performing Bloodless Surgery in Gynecologic Oncology. He speaks frequently at national meetings and serves as a principal investigator for several national clinical trials. Recently, Dr. Nagarsheth was invited by Fran Drescher (U.S. Public Diplomacy Envoy for Women's Health Issues, Founder and Visionary, Cancer Schmancer Movement, and television star) to serve on the medical advisory board for the Cancer Schmancer Movement.

In 2008, Dr. Nagarsheth joined together with five other Gynecologic Oncologists from around the country, with the support of the Gynecologic Cancer Foundation, and began an international campaign to raise awareness for gynecologic cancers through music and the arts. Dr. Nagarsheth and his talented colleagues formed the rock band N.E.D. (which stands for No Evidence of Disease) and landed a record deal with Motema Music, NYC. Their self-entitled album was released in September 2009  to rave reviews.

Dr. Nagarsheth also has been honored with a book deal from Jones and Bartlett Publishing and has written Music and Cancer, A Prescription for Healing. This book is receiving top reviews from prominent individuals ranging from celebrity cancer survivors to the Past President of the American Cancer Society and the Presidential Appointed Chair of the National Cancer Advisory Board. The book has been described as a 'must have' handbook for cancer patients and their caregivers. Proceeds from both the N.E.D. album and book are being used to start the N.E.D. Cancer Foundation, an organization founded by Dr. Nagarsheth and his colleagues with a vision on improving the quality of life of patients with gynecologic cancers.

Specialties:

  • obstetrics & gynecology

Affiliation:

  • The Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai

Activity

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, June 19 (HealthDay News) -- Vaccination against the cancer-causing human papillomavirus (HPV) is proving highly effective in reducing the spread of the sexually transmitted virus among young women, new research shows.

    The rate of new infections with strains of HPV targeted by t...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, June 18 (HealthDay News) -- Pregnant women who live in smog-filled areas may be twice as likely to have children with autism, a new study suggests.

    "The study does not prove that pollution increases risk for autism. It found an association," cautioned lead author Andrea Roberts,...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, June 18 (HealthDay News) -- Children of women who drink moderate amounts of alcohol while pregnant don't appear to have any neurodevelopmental problems when it comes to balance, a new British study suggests.

    Researchers assessed the long-term health impact of drinking while preg...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, June 11 (HealthDay News) -- While the number of women dying from breast cancer is decreasing, mammography screening can't take the credit, according to a new study from England that looked at 40 years of data.

    "We find no effect of mammographic screening on population-based breas...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, June 11 (HealthDay News) -- The U.S. government has dropped its effort to block a court order that would make the morning-after contraceptive pill available over-the-counter to all women and girls.

    After fighting for an age threshold on the nonprescription use of the Plan B One-...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, June 5 (HealthDay News) -- In the latest chapter of the legal wrangle over the non-prescription sale of "morning-after" pills, a New York appeals court on Wednesday ruled that some forms of the emergency contraception could be sold over-the-counter while the issue winds its way through...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, June 4 (HealthDay News) -- Most young women with breast cancer choose to undergo a mastectomy, new research shows.

    The other option is to have a lumpectomy, a surgical procedure that removes the tumor and some surrounding healthy tissue, but spares most of the breast. Researchers...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    MONDAY, June 3 (HealthDay News) -- In an attempt to better understand the genetics of breast cancer, new research suggests that about 20 percent of black women with the disease have an abnormality on at least one of 18 genes previously linked to breast cancer vulnerabil...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    SUNDAY, June 2 (HealthDay News) -- The cancer drug Avastin may extend the lives a bit of women with advanced cervical cancer, a new study says.

    Overall, patients given Avastin (bevacizumab) lived four months longer on average than those being treated with standard chemotherapy alone, said...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    SATURDAY, June 1 (HealthDay News) -- Women with advanced ovarian cancer stayed in remission almost six months longer when they were treated with the targeted drug pazopanib (Votrient), new German research says.

    "Our findings show that we finally have a drug that can maintain control ov...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    THURSDAY, May 30 (HealthDay News) -- Women appear to have a natural defense against the world's most common sexually transmitted infection, a new study says.

    This natural protective barrier consists mainly of lactic acid bacteria -- called lactobacilli.

    The finding appears ...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, May 29 (HealthDay News) -- Pregnant women with thyroid disorders are at greater risk for premature delivery and other pregnancy complications, a new study indicates.

    Researchers caution that these complications could have both short-term and long-term health consequences for w...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    FRIDAY, May 17 (HealthDay News) -- Too few obstetrics-gynecology residents in the United States receive formal training about menopause, which could lead to care issues for the rapidly growing number of older American women, a new study finds.

    Researchers survey...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    WEDNESDAY, May 15 (HealthDay News) -- Film star Angelina Jolie will have her ovaries removed to help lower her odds for ovarian cancer, People magazine reported Wednesday.

    The news comes just a day after Jolie, 37, revealed in an article published on the editorial page of The Ne...Full Article

  • Sharecare News
    Sharecare News posted a story about Obstetrics & Gynecology:

    TUESDAY, May 14 (HealthDay News) -- Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.

    Previous research has found that metformin was associ...Full Article